Doyle William F insider trades
Doyle William F has filed 17 Form 4s with the SEC that we hold, for Elanco Animal Health Inc (ELAN) (Director), NovoCure Ltd (NVCR) (Executive Chairman, Director), Prokidney Corp. (PROK) (Director) and Minerva Neurosciences, Inc. (NERV) (Director). Across all of them we count 2 purchases worth $499.2K and 5 sales worth $1.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($933.1K). The largest single trade was a sale of 50,557 shares of NovoCure Ltd worth $646.6K, dated 2026-03-03. The first filing on our record is dated 2021-08-04 and the latest 2026-05-29.
Elanco Animal Health Inc (ELAN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-08 | P, purchase reported on Form 4 | 15,000 | $244.5K | 2024-03-12 |
| 2024-05-21 | P, purchase reported on Form 4 | 15,000 | $254.7K | 2024-05-23 |
NovoCure Ltd (NVCR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-02 | S, sale reported on Form 4 | 995 | $148.6K | 2021-08-04 |
| 2022-03-08 | S, sale reported on Form 4 | 2,385 | $167.2K | 2022-03-09 |
| 2022-08-02 | S, sale reported on Form 4 | 837 | $58.3K | 2022-08-03 |
| 2026-03-03 | S, sale reported on Form 4 | 21,330 | $286.5K | 2026-03-05 |
| 2026-03-03 | S, sale reported on Form 4 | 50,557 | $646.6K | 2026-03-05 |
Prokidney Corp. (PROK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Minerva Neurosciences, Inc. (NERV)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1194459) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms